Patient vulnerability in stereotactic arrhythmia radioablation (STAR): a preliminary ethical appraisal from the consortium

Carlo Botrugno, Chiara Crico, Mauro Iori, Oliver Blanck, Slawomir Blamek, Pieter G. Postema, Aurelio Quesada, Etienne Pruvot, Joost J. C. Verhoeff, Ludovica de Panfilis

Research output: Contribution to journalArticleAcademicpeer-review


This preliminary ethical appraisal from the consortium is meant to raise critical points that clinicians administering stereotactic arrhythmia radioablation should consider to meet the highest standards in medical ethics and thus promote quality of life of patients recruited for radiotherapy treatments at a stage in which they experience a significant degree of vulnerability.
Original languageEnglish
JournalStrahlentherapie und Onkologie
Early online date2024
Publication statusE-pub ahead of print - 2024


  • Bioethics
  • Cardiovascular disease
  • Ethics in research
  • Stereotactic Body Radiotherapy
  • Ventricular tachycardia

Cite this